Significant Collaboration Transactions - Genomatica Inc Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2018
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Revenue remaining performance obligation amount	$ 110,000	$ 123,500
Deferred other income		222,600	$ 189,200
Revenue recognized	251,455	477,706	313,837
Genomatica
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Deferred other income	2,000	6,300
Revenue recognized	4,200	10,900	12,900
Genomatica
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront amount received						$ 40,000
Genomatica preferred stock
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Equity securities	$ 11,885	44,885
Two Thousand And Eighteen Technical Development Agreement | Variable Interest Entity, Not Primary Beneficiary | Genomatica
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Revenue remaining performance obligation amount					$ 40,000
Investment owned, at cost				$ 40,000
Foundry Terms Of Service Agreement | Variable Interest Entity, Not Primary Beneficiary | Genomatica
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront amount received		$ 8,300	$ 6,900